Cite
van Rensburg SJ, Hattingh C, Johannes C, et al. Correction to: Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS cases. Metab Brain Dis. 2021;36(6):1183-1184doi: 10.1007/s11011-021-00722-7.
van Rensburg, S. J., Hattingh, C., Johannes, C., Moremi, K. E., Peeters, A. V., van Heerden, C. J., Erasmus, R. T., Zemlin, A. E., Kemp, M. C., Jaftha, M., Khine, A. A., Potocnik, F. C. V., Whati, L., Engel-Hills, P., van Toorn, R., & Kotze, M. J. (2021). Correction to: Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS cases. Metabolic brain disease, 36(6), 1183-1184. https://doi.org/10.1007/s11011-021-00722-7
van Rensburg, Susan J, et al. "Correction to: Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS cases." Metabolic brain disease vol. 36,6 (2021): 1183-1184. doi: https://doi.org/10.1007/s11011-021-00722-7
van Rensburg SJ, Hattingh C, Johannes C, Moremi KE, Peeters AV, van Heerden CJ, Erasmus RT, Zemlin AE, Kemp MC, Jaftha M, Khine AA, Potocnik FCV, Whati L, Engel-Hills P, van Toorn R, Kotze MJ. Correction to: Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part II. Insights from two MS cases. Metab Brain Dis. 2021 Aug;36(6):1183-1184. doi: 10.1007/s11011-021-00722-7. PMID: 33909201.
Copy
Download .nbib